Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clearmind Medicine Inc. - Common Shares
(NQ:
CMND
)
0.5200
-0.0086 (-1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clearmind Medicine Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
May 15, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
May 12, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial
May 11, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
May 05, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation
April 27, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Why Is Clearmind Medicine Stock Sliding On Wednesday?
↗
April 22, 2026
Clearmind Medicine Inc. (NYSE: CMND) faces a price correction Wednesday following a massive rally. Read more on the impact of CMND-100 trial results and new executive orders.
Via
Benzinga
Top movers in Tuesday's session
↗
April 21, 2026
Via
Chartmill
Unusual volume stocks are being observed in Tuesday's session.
↗
April 21, 2026
Via
Chartmill
These stocks are moving in today's session
↗
April 21, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
April 21, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
April 21, 2026
Via
Chartmill
Kartoon Studios (NYSE: TOON) Gaining Momentum Alongside CMND, ENVB, WLDS, ANY – See Why?
April 20, 2026
Via
AB Newswire
Topics
Intellectual Property
Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care
April 20, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session.
↗
April 20, 2026
Via
Chartmill
These stocks are the most active in today's session
↗
April 20, 2026
Via
Chartmill
Unusual volume stocks are being observed in Monday's session.
↗
April 20, 2026
Via
Chartmill
What's going on in today's session
↗
April 20, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
April 20, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 20, 2026
Via
Chartmill
Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial
April 20, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
These stocks have an unusual volume in today's session
↗
April 17, 2026
Via
Chartmill
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
April 16, 2026
Via
Chartmill
These stocks are moving in today's session
↗
April 15, 2026
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Topics
Artificial Intelligence
These stocks have an unusual volume in today's session
↗
April 15, 2026
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Topics
Artificial Intelligence
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
April 15, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Top stock movements in today's session.
↗
April 14, 2026
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Topics
Artificial Intelligence
These stocks are moving in today's session
↗
April 14, 2026
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Topics
Artificial Intelligence
Tuesday's session: gap up and gap down stocks
↗
April 14, 2026
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
April 14, 2026
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via
Chartmill
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
April 14, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.